This website is available in:
To change websites, find a country in the A - Z list then choose a language.
To change websites, click on the map pins to find a country then choose a language.
HomeLife SciencesClinical Research ServicesEarly Phase I-IIaBioanalytical Services
As one of Europe’s largest bioanalytical service providers, with three GLP compliant laboratories, we are able to serve pharmaceutical and biopharmaceutical companies of all sizes with a range of tests for drug development at both preclinical and clinical stages – from early to late phase. We also develop assays (including immunassays) from scratch.
SGS bioanalysis testing is underpinned by a large list of validated methods and biomarkers, and to maintain our reputation as an industry pioneer we have actively pursued the assay development and validation of some of the more innovative of these biomarkers with our clinical teams. To date we have over 700 assays validated. Our services span:
Each service is overseen by highly skilled and trained skilled analysts, who are able to offer rapid high volume analyses that use a range of innovative techniques, including:
SGS is the world’s leading inspection, verification, testing and certification company. Our Life Science Services work with the top 20 pharmaceutical companies in the world, but every client receives the same high standard of service – no matter what their size.